Journal article
Mitral Valve Interventions in Structural Heart Disease.
- Saccocci M Heart Center University Hospital of Zurich, Department of Cardiac Surgery - UniversitätsSpital Zürich, Ramistrasse 100, 8091, Zürich, Switzerland.
- Taramasso M Heart Center University Hospital of Zurich, Department of Cardiac Surgery - UniversitätsSpital Zürich, Ramistrasse 100, 8091, Zürich, Switzerland.
- Maisano F Heart Center University Hospital of Zurich, Department of Cardiac Surgery - UniversitätsSpital Zürich, Ramistrasse 100, 8091, Zürich, Switzerland. francesco.maisano@usz.ch.
- 2018-05-18
Published in:
- Current cardiology reports. - 2018
Mitral regurgitation
Structural heart disease
TMVI
TMVREP
Transcatheter mitral valve interventions
Cardiac Catheterization
Heart Valve Prosthesis Implantation
Humans
Mitral Valve Annuloplasty
Mitral Valve Insufficiency
Recovery of Function
Surgical Instruments
Treatment Outcome
English
PURPOSE OF REVIEW
Analyze the current state of the art and the future perspectives of mitral interventions in clinical setting.
RECENT FINDINGS
A systematic and critical review of the new mitral percutaneous therapies and imaging technologies is the basis to adopt the right treatment for each patient according to specific valve dysfunction and clinical presentation, waiting for definitive guidelines. While surgical mitral repair will remain the gold standard for low-risk healthy patients with degenerative mitral regurgitation (DMR), transcatheter mitral valve repair is becoming first line therapy in high risk patients with functional mitral regurgitation (FMR). The introduction of transcatheter mitral valve replacement will expand indications for advanced DMR and FMR in inoperable patients. The introduction of transcatheter mitral interventions is changing the mitral therapy scenario. Mitral interventionalists might evolve into hybrid professional figures able to offer a tailored approach for each patient, including surgical and percutaneous approaches, depending on the anatomo-functional status of the valve, to clinical conditions, and to the timing of the intervention.
Analyze the current state of the art and the future perspectives of mitral interventions in clinical setting.
RECENT FINDINGS
A systematic and critical review of the new mitral percutaneous therapies and imaging technologies is the basis to adopt the right treatment for each patient according to specific valve dysfunction and clinical presentation, waiting for definitive guidelines. While surgical mitral repair will remain the gold standard for low-risk healthy patients with degenerative mitral regurgitation (DMR), transcatheter mitral valve repair is becoming first line therapy in high risk patients with functional mitral regurgitation (FMR). The introduction of transcatheter mitral valve replacement will expand indications for advanced DMR and FMR in inoperable patients. The introduction of transcatheter mitral interventions is changing the mitral therapy scenario. Mitral interventionalists might evolve into hybrid professional figures able to offer a tailored approach for each patient, including surgical and percutaneous approaches, depending on the anatomo-functional status of the valve, to clinical conditions, and to the timing of the intervention.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1007/s11886-018-0982-y
- PMID 29770888
- Persistent URL
- https://sonar.ch/global/documents/258245
Statistics
Document views: 27
File downloads: